# A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Source: https://onco.cc/trials/nct05908643/  
OnCo record `nct05908643` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of pTTL in colorectal cancer, run by Neogap Therapeutics AB, now recruiting.

## Summary

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer is a phase 1/2 interventional study registered as NCT05908643 by Neogap Therapeutics AB, with 16 participants planned, started 2023-03-15 and due to reach its primary completion in 2027-12. Interventions recorded: pTTL.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05908643
- Phase: 1/2
- Setting: A First-In-Human, Phase I/IIa Trial of the Novel T Cell Immunotherapy pTTL in Patients With Advanced Colorectal Cancer
- Sponsor: Neogap Therapeutics AB
- Enrolled: 16

## Sources

- ClinicalTrials.gov NCT05908643: https://clinicaltrials.gov/study/NCT05908643

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)

---
JSON: https://onco.cc/api/v1/entities/nct05908643.json